≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

HSIL lesion of the vulva

Endpoint Browser PheWeb

N14_VULVAL_HSIL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D07.1&, N90.1, N90.2
  • Hospital discharge: ICD-9 — 2333B
  • Cause of death: ICD-10 — D07.1&, N90.1, N90.2
  • Cause of death: ICD-9 — 2333B

2 out of 7 registries used, show all original rules.

587

4. Check minimum number of events

None

587

5. Include endpoints

None

587

6. Filter based on genotype QC (FinnGen only)

587

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2936 2936 -
Only index persons 2789 2789 -
Unadjusted period prevalence (%)
Whole population 0.08 0.08 -
Only index persons 0.10 0.10 -
Median age at first event (years)
Whole population - 55.85 -
Only index persons - 55.25 -

-FinnGen-

Key figures

All Female Male
Number of individuals 587 587 -
Unadjusted period prevalence (%) 0.20 0.20 -
Median age at first event (years) 56.51 56.51 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
508
Matched controls
5079
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
+∞
311.6
266
*
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
115.0
305.9
319
73
ULA02
NOMESCO Finland
Kolposcopy
49.5
290.5
406
377
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
+∞
272.1
236
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
108.8
168.3
178
25
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
+∞
142.6
130
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
12.3
133.3
301
537
LFC00
NOMESCO Finland
Partial excision of vulva
711.4
118.1
112
*
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
+∞
115.1
106
*
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
134.4
93.8
98
9
LEB00
NOMESCO Finland
Biopsy of vagina
35.9
87.3
113
40
D06BB10
ATC
imiquimod; topical
16.6
75.3
126
99
N90.0
ICD-10 Finland
Mild vulvar dysplasia
132.6
65.7
69
6
A63.0
ICD-10 Finland
Anogenital (venereal) warts
17.7
63.8
103
72
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
8.7
62.8
150
234
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
6.4
57.6
177
392
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
13.1
49.4
90
82
D07AD01
ATC
clobetasol; topical
4.7
42.1
172
501
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.6
40.9
292
1385
LDA10
NOMESCO Finland
Curettage of cervix uteri
6.9
32.8
87
148
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
49.6
31.0
37
8
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
68.1
28.3
32
5
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
30.2
25.7
34
12
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
5.7
25.6
77
153
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
94.9
24.9
27
*
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
262.2
24.9
25
*
N87.0
ICD-10 Finland
Mild cervical dysplasia
8.3
24.6
56
75
D06BB04
ATC
podophyllotoxin; topical
6.2
23.3
65
117
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
87.5
22.9
25
*
N90.4
ICD-10 Finland
Leukoplakia of vulva
28.9
22.5
30
11
N89.0
ICD-10 Finland
Mild vaginal dysplasia
54.6
22.3
26
5
N87.1
ICD-10 Finland
Moderate cervical dysplasia
8.1
22.3
51
69
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
+∞
22.0
21
*
N76.6
ICD-10 Finland
Ulceration of vulva
19.3
20.7
31
17
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.6
20.2
100
323
8070/2-C51.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of vulva, NOS
+∞
19.9
19
*
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
17.6
19.4
30
18
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
45.8
18.4
22
5
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
38.2
17.7
22
6
J02AC01
ATC
fluconazole; systemic
2.2
16.3
303
2040
B01AB10
ATC
tinzaparin; parenteral
4.0
16.2
67
184
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
87.8
15.6
17
*
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
5.9
14.5
41
75
WX002
NOMESCO Finland
Sedation and analgesia
2.5
14.1
132
633
WX320
NOMESCO Finland
Spinalanesthesy
2.3
14.0
153
793
G01AA10
ATC
clindamycin; vaginal
2.4
13.8
142
714
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
6.0
13.7
38
68
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.1
12.6
75
272
P01AB01
ATC
metronidazole; oral, rectal
2.0
12.6
261
1760
2333B
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Other and unspecified female genital organs[CARCINOMA IN SITU VULVAE]
+∞
12.5
12
*
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
20.7
12.5
18
9
L04AA06
ATC
mycophenolic acid; systemic
10.4
12.1
23
23
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.5
11.7
97
432
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.5
11.7
34
65
ZXC10
NOMESCO Finland
Use of laser
6.4
10.9
28
46
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
61.3
10.7
12
*
J01MA02
ATC
ciprofloxacin; systemic
1.9
10.6
206
1329
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
7.6
10.6
24
33
LFD10
NOMESCO Finland
Vulvectomy and excision of regional lymph nodes
33.3
10.4
13
*
UKC02
NOMESCO Finland
Cystoscopy
2.7
10.2
73
297
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.6
10.2
76
317
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
10.2
115
594
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
40.9
10.0
12
*
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
101.8
9.4
10
*
8542/3-C51.9
ICD-O-3
Paget disease, extramammary of vulva, NOS
+∞
9.4
9
*
LFC96
NOMESCO Finland
Other partial excision of vulva or perineum
+∞
9.4
9
*
LFE10
NOMESCO Finland
Plastic repair of vulva
15.9
9.1
14
9
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
37.4
9.0
11
*
LCA06
NOMESCO Finland
Biopsy of endometrium
2.2
8.9
103
536
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.9
8.8
54
199
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
8.6
180
1171
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
3.5
8.5
39
119
LFD00
NOMESCO Finland
Vulvectomy
+∞
8.4
8
*
E000001
ATC
NA
2.0
8.3
117
661
D07AB02
ATC
hydrocortisone butyrate; topical
1.8
8.2
164
1048
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
8.2
208
1438
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
8.3
8.1
17
21
E0000UV
ATC
NA
1.7
8.1
216
1511
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
8.1
144
882
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
8.7
7.9
16
19
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
45.7
7.7
9
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
5.1
7.7
23
47
ZXE00
NOMESCO Finland
One hour or less
1.7
7.6
217
1540
UJF32
NOMESCO Finland
Coloscopy
1.8
7.6
139
861
J01AA02
ATC
doxycycline; systemic
1.9
7.5
411
3528
M79.6
ICD-10 Finland
Pain in limb
1.7
7.5
202
1411
8070/3-C51.1
ICD-O-3
Squamous cell carcinoma, NOS, of labium minus
81.2
7.4
8
*
7020X
ICD-9 Finland
Other dermatoses, Actinic keratosis[DERMATOSES PRAECANCEROSAE ALIAE]
+∞
7.3
7
*
LFW96
NOMESCO Finland
Other operation on vulva or perineum
30.5
7.2
9
*
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.9
7.2
122
735
X16
ICPC
Vulval symptom/complaint
5.4
7.1
20
38
TAC99
NOMESCO Finland
Other blockade for chronic pain
12.2
7.1
12
10
A02BC02
ATC
pantoprazole; systemic
1.7
7.1
342
2796
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.4
7.0
24
57
WX702
NOMESCO Finland
Supraglottic ventilation device
2.8
7.0
42
156
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.1
7.0
86
458
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
7.7
6.9
15
20
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.7
6.9
328
2656
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
6.9
123
751
L04AX01
ATC
azathioprine; systemic
3.4
6.9
31
94
127
Kela drug reimbursment
Transplant complication
8.4
6.9
14
17
C51.00
ICD-10 Finland
Malignant tumor of the labium majus without histology
40.6
6.8
8
*
L04AA01
ATC
[U] ciclosporin; systemic
7.3
6.7
15
21
B01AB05
ATC
enoxaparin; parenteral
1.7
6.6
167
1133
L29.2
ICD-10 Finland
Pruritus vulvae
5.1
6.5
19
38
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.3
6.5
16
26
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
6.5
192
1360
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
70.7
6.4
7
*
WF002
NOMESCO Finland
Radical radiotherapy
4.3
6.4
22
53
LEB10
NOMESCO Finland
Excision of lesion of vagina
8.3
6.4
13
16
N02AX02
ATC
tramadol; systemic, rectal
1.6
6.3
209
1524
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
4.2
6.3
22
54
T89
ICPC
Diabetes insulin dependent
4.0
6.3
23
59
SPAT1153
SPAT
Removal of sutures
1.7
6.2
157
1061
ZXC00
NOMESCO Finland
Use of diathermy
7.8
6.2
13
17
Z3231
NOMESCO Finland
Registered nurse
1.7
6.1
137
892
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.7
6.1
40
157
J01DB01
ATC
cefalexin; oral
1.8
6.1
415
3644
ZZR00
NOMESCO Finland
Flap of skin
4.2
6.1
21
51
G01AF01
ATC
metronidazole; vaginal
2.0
6.1
83
460
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
6.0
201
1463
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
6.0
69
355

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3025130) Human papilloma virus identified in Specimen
157
90
23.45
200.32
3.4
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
63
30
23.40
85.12
2.9
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
320
1320
4.13
63.69
2.6
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
132
288
5.62
59.58
2.5
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
417
2257
3.93
51.72
5.1
2.0
—
—
—
0
0
(4035726)
149
452
4.08
43.72
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
161
654
3.01
28.70
1.3
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
369
2409
2.43
23.43
4.9
3.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
213
1181
2.26
18.74
2.6
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
260
1576
2.17
18.20
2.8
2.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
118
521
2.58
17.15
2.3
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
452
3559
2.17
14.04
6.3
4.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
305
2116
1.92
13.35
6.5
3.9
g/l
35.6
35.9
0.34
291
1958
(3042936) Bacteria identified in Isolate by Culture
124
652
2.14
11.75
2.4
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
476
3924
2.13
11.64
9.5
6.8
u/l
79.1
76.6
0.69
453
3673
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
351
2629
1.83
11.32
6.4
5.3
umol/l
9.3
10.1
1.40
332
2479
(3002582) Erythrocytes [#/volume] in Urine
219
1432
1.84
10.94
4.0
3.0
e6/l
17.4
66.6
2.51
177
1078
(3012095) Magnesium [Moles/volume] in Serum or Plasma
133
740
2.03
10.76
3.4
2.8
mmol/l
0.8
0.8
2.41
126
683
(3009508) Creatinine [Moles/volume] in Urine
219
1447
1.82
10.48
4.7
2.9
mmol/l
6.1
6.6
0.88
182
1206
(3018095) Leukocytes [#/volume] in Urine
252
1749
1.77
10.14
4.5
3.5
e6/l
29.2
84.8
5.24
192
1182
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
333
2518
1.75
9.78
7.3
5.7
mmol/l
1.2
1.2
1.31
272
2118
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
29
78
3.86
9.71
4.8
5.1
iu/ml
243.7
127.0
—
7
7
(3009261) Glucose [Presence] in Urine by Test strip
338
2578
1.73
9.52
4.5
3.8
estimate
0.0
0.0
0.80
61
477
(3026008) Bacteria identified in Urine by Culture
251
1777
1.72
9.16
3.5
3.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
334
2556
1.71
9.14
6.0
5.2
estimate
0.0
0.0
0.50
60
480
(3000850) Epithelial cells [#/volume] in Urine
162
1012
1.83
9.10
3.0
2.4
e6/l
8.1
8.0
0.03
140
901
(3032080) INR in Blood by Coagulation assay
257
1834
1.71
9.09
11.7
8.2
inr
1.2
1.2
0.24
60
558
(3030467) Casts [#/volume] in Urine by Automated count
198
1322
1.75
8.85
4.2
2.9
e6/l
0.2
0.4
1.81
155
980
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
226
1568
1.72
8.79
3.7
2.3
u/l
54.0
55.8
0.42
212
1447
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
303
2274
1.69
8.79
6.0
5.0
mmol/l
1.2
1.2
0.53
263
2059
(3023368) Bacteria identified in Blood by Culture
177
1146
1.78
8.79
5.1
3.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
372
2956
1.71
8.63
10.6
8.4
e9/l
4.0
3.9
0.40
332
2592
(3012516) Albumin [Mass/volume] in Urine
201
1361
1.73
8.48
4.4
3.0
mg/l
333.0
254.8
0.11
141
778
(36304419) Bacteria [Presence] in Urine
195
1311
1.73
8.43
4.1
2.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
563
5179
3.13
7.64
22.3
14.2
mmol/l
3.9
3.9
0.20
555
5020
(3019550) Sodium [Moles/volume] in Serum or Plasma
562
5167
3.06
7.59
22.1
14.1
mmol/l
139.5
139.7
1.05
553
5024
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
25
5.71
7.57
1.6
2.1
%
14.3
12.3
—
9
14
(3026782) Osmolality of Urine
145
925
1.75
7.42
3.5
2.6
mosm/kgh2o
499.7
519.9
0.53
127
798
(3013826) Glucose [Moles/volume] in Serum or Plasma
350
2800
1.62
7.34
5.1
4.2
mmol/l
6.7
6.5
0.49
330
2595
(42870588) Differential panel, method unspecified - Blood
229
1658
1.63
7.23
7.9
5.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
187
1287
1.66
7.21
2.6
2.9
ng/l
833.8
1064.4
0.57
155
1082
(3013115) Eosinophils [#/volume] in Blood
332
2629
1.61
7.21
8.0
5.7
e9/l
0.2
0.2
0.65
303
2318
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
95
538
1.91
7.13
2.9
2.1
umol/l
6.2
6.3
0.02
85
455
(3020682) Albumin/Creatinine [Ratio] in Urine
202
1422
1.64
7.11
5.2
3.8
mg/mmol
13.7
6.6
0.93
132
808
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
67
336
2.12
7.04
1.7
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
120
735
1.80
7.02
2.1
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
319
2513
1.59
7.00
8.0
5.4
e9/l
0.6
0.5
0.30
286
2178
(3006315) Basophils [#/volume] in Blood
320
2527
1.59
6.91
8.1
5.4
e9/l
0.0
0.0
0.42
286
2189
(3000991) Gas panel - Venous blood
65
325
2.12
6.88
6.4
6.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
126
789
1.76
6.82
3.7
2.6
e6/l
1.4
1.2
0.29
82
421
(3019198) Lymphocytes [#/volume] in Blood
325
2584
1.58
6.76
8.0
5.4
e9/l
1.9
1.9
0.45
300
2278
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
551
5057
2.46
6.73
21.1
12.7
mg/l
21.6
21.1
0.11
461
3938
(3011412) CD3 cells [#/volume] in Blood
15
32
4.78
6.72
2.4
2.2
e9/l
1.3
1.3
—
10
19
(40768443) Skin Pathology biopsy report
50
227
2.31
6.69
1.4
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
96
560
1.85
6.56
9.4
4.0
mmol/l
1.1
1.0
0.47
89
505
(3018418) pH of Serum or Plasma
214
1556
1.59
6.48
4.4
3.5
ph
7.4
7.4
0.03
35
294
(3018010) Neutrophils/100 leukocytes in Blood
303
2400
1.54
6.20
7.7
5.4
%
58.1
56.9
1.03
283
2228
(3015736) pH of Urine
262
2011
1.55
6.18
4.1
3.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
305
2427
1.53
6.06
8.2
5.6
%
27.8
28.8
0.93
284
2244
(3007164) IgA [Mass/volume] in Serum or Plasma
156
1067
1.63
6.01
1.5
1.5
g/l
2.0
2.2
0.90
84
630
(3035350) Ketones [Presence] in Urine by Test strip
317
2548
1.53
5.98
4.5
3.8
estimate
0.0
0.0
0.00
57
481
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
266
2073
1.52
5.72
2.2
2.0
pmol/l
98.2
98.8
0.06
127
999
(40761511) CBC panel - Blood by Automated count
564
5280
2.74
5.71
19.0
12.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
297
2370
1.51
5.69
8.6
5.8
%
8.2
8.2
0.01
277
2203
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
25
4.88
5.51
1.6
2.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
203
1503
1.54
5.49
2.3
2.1
u/l
120.2
149.0
1.15
191
1414
(3016879) Cocaine [Presence] in Urine
33
136
2.51
5.47
4.2
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
95
583
1.75
5.46
2.0
2.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
567
5334
2.85
5.45
22.4
14.6
umol/l
71.7
69.1
1.01
567
5334
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
524
4784
1.89
5.45
17.3
11.6
ml/min/173m2
80.7
81.4
0.29
457
3885
(3002032) Base excess in Venous blood by calculation
69
387
1.89
5.31
4.5
2.8
mmol/l
2.0
2.3
0.27
55
319
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
289
2321
1.48
5.21
2.5
2.3
nmol/l
82.3
78.4
1.40
248
2083
(3011397) Hemoglobin [Presence] in Urine by Test strip
166
1193
1.55
5.08
4.2
3.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
98
619
1.70
5.07
8.0
5.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
85
517
1.75
5.03
1.8
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
292
2363
1.47
4.99
8.3
5.5
%
2.8
2.8
0.19
273
2183
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
110
721
1.65
4.94
4.0
2.8
e6/l
3.3
4.5
0.87
67
353
(3027008) Opiates [Presence] in Urine
34
150
2.34
4.89
4.2
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
60
332
1.90
4.82
2.1
2.7
e9/l
68.5
74.7
0.82
48
253
(3019309) Folate [Moles/volume] in Red Blood Cells
133
921
1.57
4.76
1.8
1.7
nmol/l
1156.4
1248.9
0.54
103
682
(3028300) Cannabinoids [Presence] in Urine
34
152
2.31
4.76
4.2
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
281
2282
1.44
4.58
8.4
5.5
%
0.6
0.7
1.30
260
2104
(40758558) Short blood count panel - Blood
175
1298
1.50
4.55
7.5
6.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
76
461
1.75
4.54
2.5
2.7
%
1.8
1.9
0.30
66
409
(3026389) Candida sp identified in Specimen by Organism specific culture
20
70
2.92
4.53
1.9
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
39
189
2.14
4.51
5.0
2.8
mmol/l
24.2
24.6
0.35
34
169
(3003396) Base excess in Arterial blood by calculation
78
480
1.72
4.43
4.5
6.1
mmol/l
0.4
1.5
1.35
57
382
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
84
528
1.69
4.42
2.0
1.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
161
1181
1.50
4.40
1.7
1.6
mg/l
0.9
0.9
0.00
127
892
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
37
178
2.15
4.37
1.6
2.4
g/l
1.8
1.5
0.85
31
160
(3005719) IgG [Mass/volume] in Serum or Plasma
63
367
1.80
4.32
3.8
3.2
g/l
10.6
10.2
0.32
57
342
(3013707) Erythrocyte sedimentation rate by Westergren method
436
3870
1.49
4.28
5.7
4.2
mm/h
13.4
12.1
1.14
405
3569
(3044889) 12 lead EKG panel
401
3505
1.45
4.24
4.4
3.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
51
3.20
4.23
1.3
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
578
5589
3.23
4.21
30.3
19.1
e9/l
265.8
262.0
0.73
567
5459
(3036481) Cortisol [Moles/volume] in Serum or Plasma
78
489
1.69
4.14
2.5
2.1
nmol/l
362.7
372.1
0.13
70
455
(3000494) Fungus identified in Specimen by Culture
91
595
1.63
4.11
1.6
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
578
5592
3.19
4.07
30.5
19.2
g/l
130.4
131.9
2.18
571
5515
(3010813) Leukocytes [#/volume] in Blood
578
5592
3.19
4.07
30.3
19.1
e9/l
6.7
6.6
1.18
566
5440
(3035941) MCH [Entitic mass]
578
5591
3.20
4.06
30.1
19.0
pg
30.3
30.1
1.63
571
5514
(3026361) Erythrocytes [#/volume] in Blood
578
5591
3.20
4.06
30.3
19.1
e12/l
4.3
4.4
3.79
566
5442
(3052851) Hemolysis interference index of Serum or Plasma
29
130
2.29
4.06
3.2
2.8
—
—
—
0
0
(3024731) MCV [Entitic volume]
578
5590
3.22
4.06
30.1
19.0
fl
91.5
90.9
2.12
571
5514
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
564
5361
2.33
4.04
14.2
9.9
u/l
23.9
23.3
0.39
548
5171
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
59
344
1.80
4.04
1.7
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
84
542
1.64
4.00
21.7
21.7
inr
1.3
1.2
0.26
14
79
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
473
4291
1.53
3.98
5.0
4.5
pmol/l
14.9
14.7
0.52
440
3931
(3000764) Benzodiazepines [Presence] in Urine
32
151
2.18
3.98
4.5
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
24
100
2.46
3.94
3.7
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
47
257
1.90
3.94
6.5
3.3
ph
7.4
7.4
—
6
38
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
38
3.48
3.92
1.4
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
525
4887
1.70
3.87
6.2
5.4
mu/l
1.8
2.1
0.68
493
4506
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
80
514
1.64
3.87
2.0
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
27
120
2.31
3.86
4.6
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
19
71
2.73
3.86
6.1
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
15
6.07
3.83
2.6
2.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
45
245
1.91
3.82
6.6
3.2
mmol/l
1.4
1.9
0.35
39
189
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
47
260
1.88
3.81
6.7
3.3
kpa
5.2
5.1
0.12
42
244
(3000570) Elastase.pancreatic [Mass/mass] in Stool
33
162
2.10
3.73
1.2
1.4
ug/g
376.6
306.5
0.82
20
93
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
90
601
1.59
3.73
4.1
2.2
%
22.6
21.5
0.34
73
503
(3029634) Reagin Ab [Titer] in Serum by VDRL
15
50
3.05
3.71
1.2
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
227
1825
1.40
3.69
4.3
3.2
mmol/l
2.4
2.4
0.12
191
1596
(3027944) Amphetamines [Presence] in Urine
31
150
2.13
3.64
4.6
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
35
3.48
3.63
1.3
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
123
886
1.49
3.61
3.8
3.7
ng/l
68.9
271.2
1.53
88
643
(3049717) Cytology report of Urine Cyto stain
27
124
2.23
3.60
1.5
2.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
176
1360
1.42
3.57
4.9
4.1
estimate
0.0
0.0
0.50
60
486
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
47
266
1.83
3.56
1.7
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
135
994
1.47
3.55
1.6
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
102
709
1.53
3.54
3.8
2.1
umol/l
12.3
13.1
0.51
90
647
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
35
180
2.00
3.51
2.5
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
90
610
1.56
3.50
4.6
4.3
%
34.1
33.6
0.12
61
391
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
33
167
2.03
3.46
2.6
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
47
269
1.81
3.44
4.8
4.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
85
572
1.57
3.41
1.5
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
76
500
1.60
3.35
1.8
1.5
%
1.4
1.4
0.10
66
443
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
59
2.76
3.34
1.3
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
94
651
1.53
3.32
3.8
2.1
g/l
2.2
2.4
4.22
83
599
(3026493) Urate [Moles/volume] in Serum or Plasma
157
1204
1.41
3.30
2.8
2.4
umol/l
5160.1
6743.0
0.18
136
1042
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
77
511
1.58
3.28
1.9
1.8
—
—
—
0
0
(44790047)
13
43
3.07
3.27
1.6
1.5
—
—
—
0
0
(44790049)
13
43
3.07
3.27
1.6
1.5
—
—
—
0
0
(44806118)
13
43
3.07
3.27
1.6
1.5
—
—
—
0
0
(44790048)
13
43
3.07
3.27
1.6
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
19
78
2.48
3.24
1.6
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
371
3271
1.36
3.24
3.2
3.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
62
392
1.65
3.21
4.8
3.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
10
28
3.62
3.21
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
85
2.40
3.18
1.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
498
4625
1.51
3.17
6.8
5.4
mmol/mol
39.3
39.1
0.16
466
4278
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
44
3.00
3.15
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
33
174
1.95
3.11
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
237
1961
1.35
3.09
4.9
4.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
119
2.15
3.08
2.3
2.6
u/ml
0.4
0.4
0.08
14
74
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
8
7.56
3.06
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
75
504
1.56
3.03
5.2
3.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
25
120
2.13
3.03
1.6
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
33
176
1.93
3.02
1.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
51
2.79
3.00
1.1
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
5
10.07
2.98
2.8
3.4
—
—
—
0
0
(3013512) EKG study
175
1389
1.37
2.96
4.2
3.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
152
1179
1.39
2.96
1.5
1.5
nmol/l
22.7
22.3
0.10
132
1000
(3021589) Normoblasts [#/volume] in Blood
264
2232
1.33
2.94
12.0
8.7
e9/l
0.0
0.0
0.51
224
1826
(3015235) Bicarbonate [Moles/volume] in Capillary blood
23
108
2.18
2.94
4.0
3.1
mmol/l
24.3
25.2
0.32
17
94
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
70
2.47
2.90
1.2
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
105
765
1.45
2.89
1.5
1.3
titre
798.5
576.7
0.39
27
180
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
41
2.97
2.87
1.2
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
32
173
1.90
2.83
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
216
1783
1.33
2.81
3.8
3.5
ng/l
17.1
29.4
1.87
140
1152
(3028026) IgM [Mass/volume] in Serum or Plasma
48
295
1.68
2.79
1.9
1.7
g/l
1.4
1.4
0.01
42
271
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
125
2.04
2.75
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
277
2376
1.31
2.72
3.4
2.8
ug/l
107.7
84.8
1.27
249
2190
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
105
2.14
2.72
1.4
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
157
1241
1.36
2.70
2.8
2.1
mg/l
3.1
3.0
0.06
130
1050
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
32
3.16
2.65
1.3
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
54
347
1.61
2.65
3.8
2.5
e9/l
4.2
4.1
0.06
37
277
(3009542) Hematocrit [Volume Fraction] of Blood
492
4602
1.43
2.59
19.4
13.8
%
38.5
39.1
0.84
348
3330
(3051651) Icteric interference index of Serum or Plasma
9
25
3.64
2.58
3.2
2.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
15
62
2.46
2.56
1.5
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
108
2.08
2.55
1.4
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
24
122
2.01
2.54
1.6
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
31
174
1.83
2.47
1.5
1.2
u/ml
18.3
2.3
—
6
20
(3006462) Nitrate [Presence] in Urine
8
21
3.85
2.47
3.3
4.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
53
346
1.58
2.45
1.2
1.3
—
44.3
—
0
15
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
34
2.97
2.42
1.7
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
90
660
1.43
2.40
2.1
2.1
ug/g
248.9
109.5
0.76
63
506
(4015189)
5
8
6.29
2.37
2.6
3.6
—
—
—
0
0
(3020891) Body temperature
29
162
1.83
2.35
7.0
4.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
98
2.08
2.34
1.5
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
28
3.25
2.31
1.0
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
36
216
1.71
2.31
5.3
7.3
mmol/l
23.8
24.5
0.56
30
199
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
31
178
1.78
2.31
1.5
1.2
u/ml
2.5
9.2
—
8
31
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
365
3291
1.29
2.30
4.0
2.9
u/l
52.4
42.1
1.10
342
3067
(3019150) Specific gravity of Urine by Refractometry
142
1131
1.34
2.30
4.8
4.1
kg/l
1.0
1.0
0.83
24
163
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
79
2.19
2.27
1.5
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
17
79
2.19
2.27
1.4
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
51
337
1.56
2.26
1.5
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
506
4786
1.41
2.22
4.4
3.8
mmol/l
1.3
1.2
1.77
463
4381
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
157
1275
1.32
2.21
1.2
1.3
u/ml
0.7
1.8
1.77
30
340
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
13
54
2.44
2.21
1.2
1.1
u/l
39.1
55.0
—
8
40
(3000492) Spirometry study
65
456
1.48
2.19
1.6
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
24
3.36
2.18
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
24
3.36
2.18
1.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
14
4.32
2.15
1.0
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
35
213
1.68
2.15
5.3
7.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
167
1373
1.30
2.15
1.5
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
81
2.13
2.14
1.4
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
124
978
1.34
2.14
3.3
2.6
mmol/l
2.5
2.5
0.49
106
864
(3025941) Bacteria identified in Stool by Culture
45
293
1.58
2.13
1.4
1.2
—
—
—
0
0
(4211845)
8
25
3.23
2.10
3.3
3.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
303
1.56
2.08
1.6
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
10
5.03
2.07
1.6
1.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
10
5.03
2.07
1.8
2.6
%
8.8
4.5
—
5
10
(21494814) CD8 cells/100 lymphocytes in Specimen
5
10
5.03
2.07
1.8
2.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
61
428
1.47
2.06
2.6
2.9
u/ml
253.0
56.1
0.44
61
409
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
65
462
1.46
2.06
3.0
2.2
u/l
27.8
33.2
1.04
54
385
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
56
2.35
2.06
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
56
387
1.49
2.04
2.4
2.4
au/ml
24.0
17.0
—
5
17
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
126
1.86
2.01
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
52
356
1.51
1.98
2.5
2.9
ng/l
210.2
185.8
0.13
46
331
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
59
415
1.47
1.98
5.5
3.1
ng/l
102.7
78.0
1.20
52
368
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
105
1.94
1.98
2.0
2.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
11
4.57
1.94
1.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
11
4.57
1.94
1.2
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
260
1.58
1.92
1.6
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
97
752
1.35
1.87
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
132
1070
1.30
1.87
1.6
1.7
pmol/l
459.4
30717178.9
1.31
103
879
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
34
2.67
1.87
1.0
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
17
3.55
1.84
3.7
2.5
e9/l
0.2
0.2
—
6
17
(4198724)
6
17
3.55
1.84
3.7
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
111
881
1.32
1.83
2.2
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
143
1176
1.29
1.82
5.3
4.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
23
3.07
1.80
2.6
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
52
364
1.47
1.80
2.1
2.3
ug/l
2.2
4.5
3.56
45
317
(3022313) Gas panel - Capillary blood
30
185
1.66
1.79
8.1
3.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
191
1630
1.25
1.79
3.9
2.8
u/l
30.7
29.5
0.31
182
1557
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
74
2.05
1.76
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
23
132
1.77
1.76
1.3
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
36
234
1.57
1.75
1.8
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
210
1.61
1.75
2.4
2.0
u/l
2153.0
4103.5
0.42
12
91
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
30
2.69
1.73
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
24
2.94
1.72
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
75
2.03
1.71
1.5
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
96
755
1.32
1.69
1.9
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
40
269
1.52
1.68
3.1
2.6
g/l
124.0
128.9
0.87
40
263
(40768441) Liver Pathology biopsy report
10
42
2.40
1.68
1.2
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
19
3.18
1.66
1.0
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
31
2.60
1.66
1.6
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
67
500
1.38
1.65
1.6
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
33
214
1.57
1.63
3.5
2.8
mmol/l
25.3
25.5
0.13
33
209
(3006184) Hemoglobin [Mass/volume] in Capillary blood
18
98
1.86
1.63
3.2
1.9
g/l
121.6
129.3
—
10
72
(3034426) Prothrombin time (PT)
5
14
3.59
1.62
1.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
51
365
1.44
1.60
3.9
3.3
pmol/l
4.5
4.6
0.03
43
320
(3037756) Immunofixation for Serum or Plasma
18
99
1.84
1.59
1.1
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
26
2.71
1.58
1.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
107
1.80
1.56
4.3
3.7
%
56.5
58.3
0.23
19
107
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
22
130
1.72
1.55
1.9
1.8
ug/l
185.1
198.0
0.07
22
114
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
514
4934
1.34
1.53
5.6
4.4
mmol/l
5.9
5.8
0.79
468
4512
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
56
412
1.40
1.51
2.0
2.5
ml/min/173m2
57.0
69.4
0.84
15
168
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
31
202
1.56
1.51
6.2
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
51
2.18
1.51
3.1
2.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
28
179
1.59
1.48
1.6
1.3
miu/ml
304.3
251.8
0.30
11
82
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
31
204
1.55
1.46
1.7
2.1
u/l
34.1
39.9
0.72
25
183
(3051611) Lipemic interference index of Serum or Plasma
9
38
2.39
1.46
3.3
2.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
15
80
1.90
1.46
1.0
1.0
u/ml
2.7
1.6
—
8
40
(1002224) Polysomnography panel
31
205
1.54
1.43
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
58
436
1.37
1.39
1.2
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
41
2.21
1.37
1.3
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
23
2.62
1.37
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
23
2.62
1.37
1.2
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
64
491
1.34
1.36
3.4
3.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
31
208
1.52
1.35
2.4
2.1
%
1.3
1.1
0.42
31
208
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
105
1.74
1.34
4.3
3.3
e9/l
3.5
4.3
1.36
18
105
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
42
2.16
1.34
3.0
2.2
—
—
—
0
0
(4268621)
11
54
2.06
1.33
1.8
2.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
51
379
1.38
1.32
1.6
2.8
g/l
64.5
67.8
1.53
43
347
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
76
1.86
1.30
1.1
1.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
33
227
1.48
1.29
2.7
2.6
e6/l
0.3
0.2
0.23
33
218
(3000093) Morphology [Interpretation] in Blood Narrative
8
34
2.37
1.29
1.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
55
416
1.36
1.29
3.8
3.9
%
1.0
1.0
0.08
22
108
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
18
2.79
1.28
1.4
2.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
62
1.96
1.28
1.8
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
44
2.06
1.27
2.7
3.7
—
—
—
0
0
(4146454)
9
44
2.06
1.27
2.9
2.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
51
382
1.37
1.27
3.8
3.8
%
0.3
0.6
1.11
16
75
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
77
1.84
1.26
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
92
1.76
1.26
9.3
3.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
26
171
1.54
1.25
1.3
1.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
25
163
1.56
1.25
3.8
2.6
g/l
0.4
0.4
0.00
13
45
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
36
2.24
1.24
1.3
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
36
2.24
1.24
1.3
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
36
2.24
1.24
1.3
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
63
1.92
1.23
1.8
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
63
1.92
1.23
1.8
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
11
56
1.98
1.22
2.1
1.9
%
65.3
57.7
—
6
37
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
19
2.65
1.22
1.2
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
19
2.65
1.22
1.0
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
27
181
1.52
1.20
6.4
1.4
g/l
1.1
1.2
0.93
27
171
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.2
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.2
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
87
1.74
1.16
1.0
1.2
u/ml
2.2
6.3
—
9
32
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
30
2.35
1.12
1.1
1.1
—
—
—
0
0
(4281824)
13
73
1.80
1.11
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
73
1.80
1.11
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
515
4985
1.27
1.11
4.9
4.2
mmol/l
1.5
1.6
1.47
471
4603
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
261
1.40
1.10
1.6
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
66
1.84
1.09
1.8
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
66
1.84
1.09
1.8
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
66
1.84
1.09
1.8
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
56
438
1.31
1.07
5.4
3.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
51
394
1.32
1.07
4.1
4.0
%
0.0
0.1
0.80
21
97
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
33
2.13
1.06
1.4
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
22
146
1.53
1.04
1.9
1.8
%
93.3
97.9
0.42
22
137
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
46
1.97
1.04
1.2
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.2
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
34
2.07
1.03
1.1
1.2
—
—
—
0
0
(4010399)
47
361
1.33
1.03
1.6
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
48
1.89
1.01
2.9
2.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
49
381
1.31
0.99
4.0
4.0
%
0.0
1.2
0.55
17
80
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
36
1.96
0.97
1.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
525
5108
1.26
0.97
5.6
4.8
mmol/l
2.7
2.8
1.54
482
4712
(3021901) Oxygen saturation in Capillary blood
13
77
1.70
0.96
5.5
2.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
25
175
1.45
0.94
6.8
1.5
g/l
0.2
0.2
0.19
25
167
(3020191) Ethanol [Moles/volume] in Serum or Plasma
6
27
2.23
0.93
1.3
1.7
promille
0.4
1.0
—
6
20
(3015183) Erythrocyte sedimentation rate
6
27
2.23
0.93
1.7
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
270
1.36
0.93
1.4
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
134
1.51
0.93
1.2
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
52
1.74
0.92
1.7
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
38
288
1.34
0.92
1.1
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.2
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
44
343
1.31
0.89
3.5
2.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
95
1.59
0.88
1.1
2.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
35
456
0.75
0.87
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
515
5013
1.22
0.85
5.1
4.3
mmol/l
4.7
4.8
1.55
476
4648
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
137
1.48
0.85
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
157
1405
1.16
0.85
4.4
3.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
31
1.94
0.84
1.7
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
31
1.94
0.84
1.8
1.4
ug/l
14.7
26.3
—
6
31
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
45
1.79
0.84
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
45
1.79
0.84
1.5
2.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
129
1.49
0.84
2.2
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
105
1.54
0.82
1.4
4.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
59
1.71
0.76
2.5
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
54
1.68
0.75
1.3
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
109
0.55
0.73
2.0
1.6
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
7
39
1.80
0.72
1.0
1.1
mg/l
29.1
24.7
—
7
33
(3042631) Mycobacterium sp identified in Specimen
9
56
1.62
0.72
3.2
2.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
68
1.63
0.72
4.2
1.7
%
50.8
59.4
0.56
11
68
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
27
203
1.35
0.72
1.6
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
40
1.76
0.71
1.0
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
59
493
1.22
0.70
1.6
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
116
1030
1.16
0.70
1.3
1.3
iu/ml
21.1
30.9
0.97
28
338
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
110
1.47
0.69
1.8
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
77
1.57
0.69
1.3
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
136
1.41
0.67
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
153
1392
1.13
0.65
1.8
1.6
mmol/l
1.4
1.3
0.35
132
1181
(21494890) Protein electrophoresis panel - 24 hour Urine
7
44
1.60
0.65
1.0
2.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
95
1.49
0.64
4.1
2.3
%
15.9
16.0
—
8
45
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
87
1.51
0.63
1.0
1.1
u/ml
1.3
1.9
—
7
26
(40768793) Breast Pathology biopsy report
27
208
1.31
0.63
1.4
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
113
1.43
0.61
1.4
1.5
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
20
0.00
0.60
0.0
1.0
—
111.1
—
0
9
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
157
1.35
0.60
1.4
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
64
1.57
0.59
1.0
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
50
421
1.21
0.58
4.8
3.5
mmol/l
1.2
1.2
0.39
42
364
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
54
1.49
0.57
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
55
1.46
0.56
1.1
1.8
pg
31.5
31.5
—
8
55
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
90
0.55
0.56
1.6
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
41
340
1.22
0.55
1.4
2.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
82
1.47
0.54
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
82
1.47
0.54
1.1
1.1
—
—
—
0
0
(4306422)
11
74
1.50
0.53
1.2
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
13
91
1.44
0.53
3.7
3.6
nmol/l
0.7
0.8
—
8
70
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
91
1.44
0.53
1.8
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
91
1.44
0.53
1.8
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
62
1.46
0.53
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
39
1.54
0.53
1.2
1.7
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
39
1.54
0.53
1.8
1.9
mmol/l
6.6
6.5
—
6
26
(3009466) Valproate [Moles/volume] in Serum or Plasma
10
66
1.52
0.53
4.7
5.5
umol/l
323.0
393.9
—
10
59
(3024980) IgG subclass 4 [Mass/volume] in Serum
10
66
1.52
0.53
1.2
1.7
g/l
0.4
0.6
—
10
51
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
52
445
1.18
0.52
1.1
1.2
iu/ml
106.5
157.8
0.44
14
190
(4024509)
6
40
1.51
0.51
1.5
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
75
1.48
0.51
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
13
92
1.42
0.51
2.5
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
224
0.75
0.50
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
45
1.56
0.49
2.6
3.6
—
—
—
0
0
(44813793)
7
47
1.50
0.47
1.0
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
19
146
1.31
0.47
1.5
1.2
mg/l
843.5
457.0
0.47
19
135
(1761868) Lipid panel - Serum or Plasma
168
1795
0.91
0.46
2.9
2.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
11
77
1.44
0.46
1.3
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
438
4272
1.10
0.44
23.0
15.6
%
13.7
13.6
0.19
429
4187
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
176
1.26
0.42
1.4
2.2
g/l
9.2
10.2
0.31
16
156
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
19
149
1.28
0.42
1.9
1.6
—
188.6
—
0
7
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
32
1.57
0.42
2.6
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
57
1.41
0.42
1.1
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
5
33
1.52
0.41
1.6
1.2
e6/l
1760.4
1053.5
—
5
22
(4027681)
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
102.2
—
0
15
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.1
—
0.6
—
0
10
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
79
1.40
0.41
1.1
1.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
18
0.00
0.40
0.0
1.4
—
5.9
—
0
12
(3022806) Fractional oxyhemoglobin in Capillary blood
8
61
1.32
0.39
1.8
2.1
%
90.7
90.0
—
8
61
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
169
1.25
0.39
1.4
2.2
g/l
3.2
3.2
0.03
15
143
(4094501)
16
125
1.29
0.37
1.1
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
71
1.27
0.36
1.1
1.2
nmol/l
—
—
—
0
0
(4034850)
19
153
1.25
0.36
10.5
9.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
67
605
1.12
0.35
1.6
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
124
0.72
0.35
1.3
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
181
1.22
0.35
1.4
2.2
g/l
3.5
3.7
0.34
15
141
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
23
275
0.83
0.34
1.5
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
182
1.22
0.33
1.4
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
182
1.22
0.33
1.4
2.1
g/l
7.9
7.7
0.19
15
145
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
55
494
1.13
0.32
3.5
3.7
ug/l
3.9
9.5
2.37
41
394
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
74
1.36
0.32
1.1
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
57
1.23
0.29
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
129
0.77
0.28
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
22
186
1.19
0.28
1.5
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
26
300
0.86
0.27
1.2
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
128
0.78
0.27
1.5
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
77
1.30
0.26
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
76
1.19
0.24
2.1
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
40
1.25
0.22
1.2
1.4
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.0
—
118.5
—
0
11
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
1.6
—
0
10
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
98
1.23
0.21
6.0
2.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.4
—
0.5
—
0
7
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
134
0.82
0.21
1.6
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
14
117
1.20
0.20
3.1
1.8
e6/l
9281.0
17751.9
0.63
14
82
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
53
1.13
0.18
1.3
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
62
1.13
0.17
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
62
1.13
0.17
1.4
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
63
1.11
0.17
1.6
2.1
mmol/l
105.6
105.5
—
7
63
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
63
1.11
0.17
1.6
2.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
63
1.11
0.17
1.6
2.1
mmol/l
3.9
4.0
—
7
63
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
430
0.93
0.15
1.7
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
170
0.88
0.14
1.7
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
170
1.12
0.13
2.8
1.9
iu/l
2.7
4.3
—
8
56
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
151
1.13
0.13
1.1
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
159
0.88
0.13
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
159
0.88
0.13
1.4
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
105
1015
1.04
0.12
1.3
1.3
u/ml
2.4
10.9
4.40
30
387
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
158
0.88
0.12
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
158
0.88
0.12
1.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
260
1.08
0.11
2.2
2.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
19
208
0.91
0.10
1.2
1.8
mg/l
1.8
2.4
0.35
14
152
(3024139) IgG subclass 3 [Mass/volume] in Serum
5
44
1.14
0.10
1.2
1.3
g/l
0.2
0.3
—
5
32
(3028192) IgG subclass 2 [Mass/volume] in Serum
5
44
1.14
0.10
1.2
1.3
g/l
2.2
2.6
—
5
31
(3027135) IgG subclass 1 [Mass/volume] in Serum
5
44
1.14
0.10
1.2
1.3
g/l
7.7
7.2
—
5
32
(4062490)
5
45
1.11
0.10
1.2
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
87
1.15
0.09
1.4
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
48
1.04
0.09
1.2
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
17
185
0.92
0.08
1.5
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
63
0.79
0.08
1.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
64
1.09
0.08
1.0
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
65
1.08
0.08
5.0
2.3
%
13.1
13.4
—
7
65
(1761482) Bacteria [#/volume] in Urine by Culture
11
122
0.90
0.07
6.5
4.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
388
1.03
0.04
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
250
0.96
0.03
5.7
3.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
36
354
1.02
0.00
1.9
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
126
1.03
0.00
2.4
2.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
32
322
0.99
0.00
1.2
1.3
iu/l
34.3
30.8
0.20
26
286
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
5.2
—
0
9
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
77.3
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
100
1.00
0.00
1.3
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
85
0.94
0.00
2.5
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
71
0.99
0.00
1.1
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
59
0.85
0.00
1.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
3.7
—
0.6
—
0
7
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
1.5
—
107.5
—
0
8
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.3
—
0
5
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
64
0.94
0.00
1.2
2.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3024471) HLA-A [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.2
—
0.3
—
0
6
(3016330) Potassium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
71
0.99
0.00
1.1
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint N14_VULVAL_HSIL and mortality.

Females

Parameter HR [95% CI] p-value
N14_VULVAL_HSIL 1.464 [1.23, 1.74] < 0.001
Birth year 0.993 [0.98, 1.0] 0.114

During the follow-up period (1.1.1998 — 31.12.2019), 378 out of 2373 females with N14_VULVAL_HSIL died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_VULVAL_HSIL.

N-year risk Females Males
1 0.119% No data
5 0.772% No data
10 2.04% No data
15 3.618% No data
20 6.301% No data

Relationships between endpoints

↥

Index endpoint: N14_VULVAL_HSIL – HSIL lesion of the vulva

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data